Richard E Litov

Title: Richard E. Litov: Innovator in Oral Rehydration Solutions

Introduction

Richard E. Litov is a notable inventor based in Evansville, Indiana, known for his contribution to oral rehydration solutions. With a focus on improving health outcomes, Litov's innovative approach aims to provide more effective treatment for infants suffering from chronic diarrhea through a unique formulation.

Latest Patents

Litov holds a patent for an advanced oral rehydration solution that comprises a mixture of rice dextrin and essential electrolytes. His patent details how rice dextrin exhibits superior functionality compared to glucose, resulting in lower stool output and enhanced water retention for infants. The formulation harnesses rice dextrin’s polymer profile, which delivers more readily available glucose than traditional alternatives such as corn dextrin or rice flour. Additionally, the patent outlines a process for clarifying rice dextrin solutions, involving a two-step filtration process at specified temperatures.

Career Highlights

Richard E. Litov is employed with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on the development of advanced medical solutions, particularly in the area of hydration therapies. His innovative patent reflects his commitment to improving pediatric health care and showcases his ability to translate complex biochemical concepts into practical medical applications.

Collaborations

Throughout his career, Litov has collaborated with esteemed colleagues such as Michael C. Tao and John R. Euber. These collaborations have likely contributed to the refinement of his research and the practical application of his inventions, fostering an environment of innovation within the field of healthcare.

Conclusion

Richard E. Litov's contributions to oral rehydration solutions exemplify the intersection of innovation and healthcare. His patent not only addresses critical health issues faced by infants but also highlights the importance of scientific collaboration in the development of effective medical therapies. Through his work at Bristol-Myers Squibb and his partnerships with fellow researchers, Litov continues to pave the way for improvements in pediatric health solutions.